Proactive Investors - Run By Investors For Investors
Market: AIM
52-week High/Low: 25.00p / 12.15p
Sector: Pharma & Biotech
Market Cap: 12.36M
Evgen Pharma

Evgen Pharma

Evgen Pharma plc, a clinical stage drug development company focused on the treatment of cancer and neurological conditions.

Evgen Pharma

Interactive graph

col 3
col 4
col 5
col 6

Evgen Pharma RNS Announcements

Date Epic Announcement
20/03/2018 EVG Research Collaboration with Imperial College
05/03/2018 EVG Update on Novel Sulforaphane Analogues
15/01/2018 EVG Poster Presentation of SFX-01 Mechanistic Data
10/01/2018 EVG Notification of Major Interest in Shares
05/01/2018 EVG Notification of Major Interest in Shares
05/01/2018 EVG Notification of Major Interest in Shares
02/01/2018 EVG Total Voting Rights
28/12/2017 EVG Result of General Meeting
22/12/2017 EVG Grant of Options
13/12/2017 EVG Collaboration with King's College London
11/12/2017 EVG Hardman Res.: Funded to the end of Phase II trials
08/12/2017 EVG Placing and Notice of General Meeting
08/12/2017 EVG Interim Results
23/11/2017 EVG Second Price Monitoring Extn
23/11/2017 EVG Price Monitoring Extension
04/10/2017 EVG First European Patent Grant
31/08/2017 EVG Issue of Equity and Total Voting Rights
02/08/2017 EVG SFX-01 data published in Peer Reviewed Journal
26/07/2017 EVG AGM Statement
11/07/2017 EVG Charity-funded Study of SFX-01 in TNBC
21/06/2017 EVG Posting of Annual Report and AGM Notice
21/06/2017 EVG Hardman Research: Making clinical progress
13/06/2017 EVG Full Year Results
01/06/2017 EVG Compassionate Use Programme and Trials Update
25/05/2017 EVG Notice of Preliminary Results
05/12/2016 EVG Half Yearly Report
17/11/2016 EVG Notice of Interim Results
01/11/2016 EVG Grant of Options
15/09/2016 EVG Update re SFX-01 Data at ECTRIMS 2016
08/09/2016 EVG Presentation of SFX-01 Data at ECTRIMS 2016

© Proactive Investors 2018

Proactive Investor UK Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use